2-{5-[(2S)-2-Pyrrolidinyl]-1,2,4-oxadiazol-3-yl}pyridine trifluoroacetate, 95.0%, 10g

2-(3-Chloro-4-methoxyphenyl)oxirane, 98%, 1g

2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide, 95.0%, 10g

6-(2,3-Dimethylphenyl)nicotinaldehyde, 95.0%, 1g

8-Chloro-7-iodo-2-methylimidazo[1,2-a]pyridine, 97%, 250mg

Tert-butyl(1r,4r)-6-oxo-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate, 98%, 100mg

GC capillary column ROTI®Cap-5, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

2-Chloro-3,5-difluorobenzoic acid, 95.0%, 100mg

5-Amino-6-methyl-pyrimidine-2,4-diol, 97%, 100g

1-methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, 5g

7-METHYL-1,2,3,4-TETRAHYDROQUINOLINE, 95%, 5g

4-Bromocatechol>98.0%(GC)1g

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 98.0%, 5g